-
Despite his modesty about his work and life, James L. Reinertsen, MD, received a 2010 John M. Eisenberg Patient Safety and Quality award for individual achievement from The Joint Commission and the National Quality Forum.
-
From new and revised standards to new levels of accreditation, this year will bring some changes in Joint Commission expectations.
-
When Intermountain Healthcare's LDS Hospital joined with the Joint Commission Center for Transforming Healthcare and nine other hospitals to work on hand-offs, the health system's associate chief medical officer says the first step was identifying which hand-offs the hospital wanted to work on.
-
[In the first two articles of this series, Vicki Searcy, president, consulting services at Morrisey Associates Inc. in Chicago, introduced the four basic components of clinical privileging as well as creating criteria for privileges:
-
It was the first Joint Commission survey for Elizabeth Donnenwirth, RN, accreditation/sharps safety specialist at Winchester Hospital in Winchester, MA. But she says there weren't many surprises.
-
-
The results of this well-done study suggest that a specific formulation of echinacea may offer modest benefit to people with the common cold, but that such benefit is statistically, and likely clinically, insignificant. Data from the trial relating to physician-patient interaction and clinical response have yet to be published.
-
Findings of this ground-breaking randomized controlled trial suggest that patients with irritable bowel syndrome who receive treatment with placebo tablets, and who are fully aware that they are taking a placebo, have significantly greater relief of symptoms compared with patients who receive no treatment at all. Accessing the placebo effect may not require deception at all.
-
-
Glucosamine sulfate continues to grow in popularity as a treatment for osteoarthritis. Global sales reached almost $2 billion in 2008, an increase of 60 percent over the previous five years.
